Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
BIOD: Stock Quote & Summary Data
10.67%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | N/A |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 83,401 |
| Previous Close | $ 3.75 |
| 52 Wk High / Low | $ 6.02 / $ 2.19 |
| Shares Outstanding | 23,800,000 |
| Market Value | $ 98,770,000 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.71 |
| NASDAQ Official Open Price: | $ 3.72 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 4.15 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About BIOD?
Ask your question about about Biodel Inc. (BIOD) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
We are a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders such as diabetes and osteoporosis, which may be safer, more effective and convenient. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic results. Our initial development efforts are focused on peptide hormones. We have two insulin product candidates currently in clinical trials for the treatment of diabetes. Additionally, we have two preclinical product candidates for the treatment of osteoporosis, one with parathyroid hormone 1-34 and the other with salmon calcitonin. Our most advanced product candidate is VIAjecttm, a proprietary injectable formulation of recombinant human insulin designed to be absorbed into the blood faster than currently marketed rapid-acting insulin products. ... More ...
Links to all Biodel Inc. (BIOD) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for BIOD |
||
|
Biodel Inc. to Present at Oppenheimer 20th Annual Healthcare Conference on November 3rd, 2009 - Business Wire 10/30/2009 7:00AM |
||
|
Biodel Inc. to Present at Morgan Stanley 2009 Global Healthcare Unplugged Conference on September 14th, 2009 - Business Wire 09/11/2009 7:00AM |
||
|
Biodel Q3 Loss Widens - Update - RTT News 08/07/2009 8:47AM |
||
|
Biodel Q3 09 Earnings Conference Call At 9:00 AM - RTT News 08/07/2009 7:23AM |
||
|
Biodel Q3 Loss Widens - Quick Facts - RTT News 08/07/2009 7:22AM |
||
|
Biodel Reports Third Quarter Fiscal Year 2009 Financial Results - Business Wire 08/07/2009 7:00AM |
||
|
Biodel to Report Third Quarter Fiscal Year 2009 Results on August 7, 2009 - Business Wire 08/03/2009 7:00AM |
